Revamping Health Management for Sustainable Development Goals: Insights from Kenya, Malawi, and Uganda

By Staff Writer

July 17, 2023

The potential of Primary Health Care (PHC) in achieving the Sustainable Development Goals (SDGs) is widely acknowledged. In Eastern and Southern Africa, governments have been progressively decentralising health decision-making, making health management a critical aspect of PHC performance. A study published by Oxford, conducted an in-depth political economy analysis in Kenya, Malawi, and Uganda, focusing on local decision-making environments and their impact on health management and governance practices. 

The study involved a comprehensive set of questions for key informants regarding health planning, budgeting, and implementation. These included understanding local processes and their deviations from established guidelines, identification of local health priorities, the impact of health system arrangements such as decentralisation and governance on health plans, and the dynamics of power relationships among the involved actors. The study also explored the processes for community engagement and gathered suggestions for improving the planning process.

 

Findings highlight several complex issues that need attention to strengthen health management and governance. These range from unfinished reforms under decentralisation, underfunded health plans, to counterproductive working environments for managers. 

Their recommendations aim to address these issues by focusing on managerial capacity, community engagement, coordination, and innovative financing. These small improvements can make the overall system more functional and effective. 

However, these challenges are complex and systemic, requiring leadership and engagement from government actors at multiple levels. The ongoing COVID-19 pandemic has further emphasised the need for resilient health systems and a crisis response mechanism.

Reference url

Recent Posts

Novo Nordisk performance
      

Business Dynamics: How Novo Nordisk Lost GLP-1 Market Share

🚀 Understand the market dynamics of Novo Nordisk’s GLP-1 Market Share Decline.

A case of demand underestimation, supply chain strain, and competitor agility. Using systems thinking, we unpack the dynamic forces behind Eli Lilly’s surge—and what strategic levers pharma leaders must pull to stay ahead.

#SyenzaNews #PharmaStrategy #MarketDynamics #NovoNordisk #EliLilly #GLP1

Tolebrutinib MS analysis
          

Tolebrutinib MS Analysis: Evaluating Economic Impact in SPMS

💡 Can tolebrutinib reshape the treatment landscape for progressive multiple sclerosis?

A recent report from the Institute for Clinical and Economic Review reveals promising insights on tolebrutinib, demonstrating a 31% reduction in disability progression for patients with non-relapsing secondary progressive MS. Yet, mixed outcomes and potential safety concerns raise critical questions about its long-term efficacy and market access.

Explore the nuances of this groundbreaking therapy and its implications for healthcare economics.

#SyenzaNews #HealthEconomics #MarketAccess

allopurinol Marfan syndrome orphan
       

Allopurinol Designated an Orphan Drug for Marfan Syndrome

🌟 What does the EMA’s orphan drug designation for allopurinol mean for those impacted by Marfan syndrome?

This groundbreaking move highlights a significant step forward in tackling rare diseases, offering hope to patients with limited treatment options. Allopurinol, traditionally used for gout, shows promise in addressing life-threatening aortic complications associated with Marfan syndrome, thanks to its antioxidant properties.

Dive into the implications of this development for healthcare innovation, patient access, and the future of rare disease treatment!

#SyenzaNews #HealthEconomics #Innovation #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.